Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
A Study of Isatuximab-based Therapy in Participants With Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)
- Status
- COMPLETED
- Phase
- PHASE2
KN046 in Subjects With Advanced Solid Tumors and Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
GR1405 Injection in Patients With Advanced Solid Tumor or Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies
- Status
- SUSPENDED
- Phase
- PHASE1
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
- Status
- RECRUITING
- Phase
- N/A
Effect on Patient Quality of Life of Taking Into Account the Spiritual Dimension in Nurse's Care for Haematologic Cancers.
- Status
- COMPLETED
- Phase
- N/A
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Multi-center, Prospective, Single-blind, Controlled Trial Comparing Diagnostic Value of Different EUS-FNA Techniques
- Status
- UNKNOWN
- Phase
- NA
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE3
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Managed Access Programs for CTL019, Tisagenlecleucel
- Status
- AVAILABLE
- Phase
- N/A
Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant
- Status
- TERMINATED
- Phase
- PHASE1